Are you Dr. Zweig?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 56 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1501 Kings Hwy
Department Of Neurology
Shreveport, LA 71103Phone+1 318-675-7737Fax+1 318-675-5666
Summary
- Dr. Richard Zweig, MD is a board certified neurologist in Shreveport, Louisiana. He is currently licensed to practice medicine in Louisiana, Nevada, and Maryland. He is affiliated with Ochsner LSU Health Shreveport - Academic Medical Center and Ochsner LSU Health Shreveport.
Education & Training
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 1983 - 1987
- George Washington UniversityResidency, Neurology, 1981 - 1983
- University of Texas Health Science Center at HoustonResidency, Neurology, 1980 - 1981
- The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1978 - 1980
- Case Western Reserve University School of MedicineClass of 1978
Certifications & Licensure
- LA State Medical License 1991 - 2022
- MD State Medical License 1984 - 1993
- NV State Medical License 1987 - 1993
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 4211 citationsMovement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn
Movement Disorders. 2008-11-15 - 163 citationsEfficient Neuronal Gene Transfer with AAV8 Leads to Neurotoxic Levels of Tau or Green Fluorescent ProteinsRonald Klein, Robert D. Dayton, Nancy J. Leidenheimer, Karen Jansen, Todd E. Golde
Molecular Therapy. 2006-03-01 - 164 citationsPioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trialTanya Simuni, Karl Kieburtz, Barbara C. Tilley, Jordan J. Elm, Bernard Ravina
The Lancet. Neurology. 2015-08-01
Professional Memberships
- Member